This is a randomized, double-blind, placebo-controlled, parallel-group, Phase 4, 3-group study to assess whether treatment with sarilumab at either 150 mg q2w …

Polymyalgia Rheumatica

~Estimated

~$10 – $7,500

SanofiNCT07286214

Rheumatology Patient Registry and Biorepository

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Rheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more

~Estimated

~$10 – $750

Yale UniversityNCT04402086

A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy

To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.

ArthritisPolymyalgia RheumaticaImmune Checkpoint Inhibitors

~Estimated

~$10 – $750

M.D. Anderson Cancer CenterNCT06647134